Publications by authors named "Venugopal Vijayan"

Claim this Profile
M
Mechanistic insights into the beneficial effects of curcumin on insulin resistance: Opportunities and challenges.
Pitchai Balakumar, Kumar Venkatesan, Noohu Abdulla Khan, N M Raghavendra, Vijayan Venugopal

Drug Discov Today· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syntheses, in vitro, and in silico studies of rhodanine-based schiff bases as potential α-amylase inhibitors and radicals (DPPH and ABTS) scavengers.
Samuel Attah Egu, Irfan Ali, Khalid Mohammed Khan, Sridevi Chigurupati, Urooj Qureshi, Vijayan Venugopal

Mol Divers· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New pyrrolopyridine-based thiazolotriazoles as diabetics inhibitors: enzymatic kinetics and  study.
Muhammad Taha, Fazal Rahim, Shawkat Hayat, Sridevi Chigurupati, Khalid Mohammed Khan, Vijayan Venugopal

Future Med Chem· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.
Oluwatoyin Babatunde, Shehryar Hameed, Uzma Salar, Sridevi Chigurupati, Abdul Wadood, Vijayan Venugopal

Mol Divers· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
Muhammad Taha, Ahlam Sayer Alrashedy, Noor Barak Almandil, Naveed Iqbal, El Hassane Anouar, Vijayan Venugopal

Int J Biol Macromol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Green Synthesis and Characterization of Silver Nanoparticles Using Extract and Their Antimicrobial Activity against Biofilm-Producing Bacteria.
Sumitha Samuggam, Suresh V Chinni, Prasanna Mutusamy, Subash C B Gopinath, Periasamy Anbu, Vijayan Venugopal

Molecules· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring efficacy of indole-based dual inhibitors for α-glucosidase and α-amylase enzymes: In silico, biochemical and kinetic studies.
Abdel-Nasser Kawde, Muhammad Taha, Raneem Saud Alansari, Noor Barak Almandil, El Hassane Anouar, Venugopal Vijayan

Int J Biol Macromol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, in vitro α-amylase inhibitory, and radicals (DPPH & ABTS) scavenging potentials of new N-sulfonohydrazide substituted indazoles.
Rafaila Rafique, Khalid Mohammed Khan, Arshia, Sridevi Chigurupati, Abdul Wadood, Vijayan Venugopal

Bioorg Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Paclitaxel-Loaded PLGA Nanoparticles on MDA-MB Type Cell Lines: Apoptosis and Cytotoxicity Studies.
Venugopal Vijayan, Krishnan Shalini, V Yugesvaran, Teh Hui Yee, Siventhiran Balakrishnan

Curr Pharm Des· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
Shehryar Hameed, Kanwal, Faiza Seraj, Rafaila Rafique, Sridevi Chigurupati, Vijayan Venugopal

Eur J Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Regulatory Considerations for Nanomedicines.
T S Subin, Venugopal Vijayan, K Jaya R Kumar

Pharm Nanotechnol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
Vijayan Venugopal, Shalini Krishnan, Vasanth Raj Palanimuthu, Subin Sankarankutty, Jayaraja Kumar Kalaimani

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2'-Aryl and 4'-arylidene substituted pyrazolones: As potential α-amylase inhibitors.
Sahar Yousuf, Khalid Mohammed Khan, Uzma Salar, Sridevi Chigurupati, Munira Taj Muhammad, Venugopal Vijayan

Eur J Med Chem· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis